Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia

Monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML) plays an important role in predicting relapse and outcome. The applicability of the leukemia-initiating nucleophosmin1 (NPM1) gene mutations in MRD detection is well-established, while that of isocitrate dehydrogenase1/2 (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kövy, Petra, Őrfi, Zoltán, Bors, András, Kozma, András, Gopcsa, László, Dolgos, János, Lovas, Nóra, Harasztdombi, József, Lakatos, Viktor, Király, Ágnes, Mikala, Gábor, Vályi-Nagy, István, Reményi, Péter, Andrikovics, Hajnalka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216517/
https://www.ncbi.nlm.nih.gov/pubmed/34153064
http://dx.doi.org/10.1371/journal.pone.0253386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216517/
https://www.ncbi.nlm.nih.gov/pubmed/34153064
http://dx.doi.org/10.1371/journal.pone.0253386

Ejemplares similares